Chemotherapy resistance in advanced ovarian cancer patients

R Pokhriyal, R Hariprasad, L Kumar… - Biomarkers in …, 2019 - journals.sagepub.com
Ovarian cancer is the seventh most common gynaecologic malignancy seen in women.
Majority of the patients with ovarian cancer are diagnosed at the advanced stage making …

Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route

I Panarese, G Aquino, A Ronchi, F Longo… - Expert review of …, 2019 - Taylor & Francis
Introduction: Oral and oropharyngeal squamous cell carcinoma (OSCC and OPSCC)
represents an increasing problem in the global public health. Indeed, squamous cell …

The human immune cell simulated anti-breast cancer nanorobot: the efficient, traceable, and dirigible anticancer bio-bot

SMR Seyedi, A Asoodeh, M Darroudi - Cancer Nanotechnology, 2022 - Springer
Background Various types of cancer therapy strategies have been investigated and
successfully applied so far. There are a few modern strategies for improving drug selectivity …

Emerging role of G-quadruplex DNA as target in anticancer therapy

G Cimino-Reale, N Zaffaroni… - Current Pharmaceutical …, 2016 - ingentaconnect.com
DNA has represented the most exploited target for the development of anticancer agents. It
is now established that DNA may assume a variety of non-B conformations. This evidence …

Unlocking the NF-κB conundrum: embracing complexity to achieve specificity

F Begalli, J Bennett, D Capece, D Verzella, D D'Andrea… - Biomedicines, 2017 - mdpi.com
Transcription factors of the nuclear factor κB (NF-κB) family are central coordinating
regulators of the host defence responses to stress, injury and infection. Aberrant NF-κB …

Long non-coding RNA TUG1 promotes cell proliferation and metastasis in human breast cancer

T Li, Y Liu, H Xiao, G Xu - Breast Cancer, 2017 - Springer
Abstract Background Long non-coding RNAs (LncRNAs) utilize a wide variety of
mechanisms to regulate RNAs or proteins on the transcriptional or post-transcriptional …

Coumarin-acetohydrazide derivatives as novel antiproliferative agents via VEGFR-2/AKT axis inhibition and apoptosis triggering

LMAA Ghany, NM El-Dydamony, AA Helwa… - New Journal of …, 2022 - pubs.rsc.org
The VEGFR-2/AKT pathway is a crucial axis in tumor survival where it is highly dysregulated
in many cancer types. In this research, novel coumarin-acid hydrazides were synthesized …

Formononetin regulates multiple oncogenic signaling cascades and enhances sensitivity to bortezomib in a multiple myeloma mouse model

C Kim, JH Lee, JH Ko, A Chinnathambi, SA Alharbi… - Biomolecules, 2019 - mdpi.com
Here, we determined the anti-neoplastic actions of formononetin (FT) against multiple
myeloma (MM) and elucidated its possible mode of action. It was observed that FT …

The potential role of exosomal proteins in prostate cancer

S Feng, K Lou, X Zou, J Zou, G Zhang - Frontiers in Oncology, 2022 - frontiersin.org
Prostate cancer is the most prevalent malignant tumor in men across developed countries.
Traditional diagnostic and therapeutic methods for this tumor have become increasingly …

Staurosporine suppresses survival of HepG2 cancer cells through Omi/HtrA2-mediated inhibition of PI3K/Akt signaling pathway

Y Ding, B Wang, X Chen, Y Zhou, J Ge - Tumor Biology, 2017 - journals.sagepub.com
Staurosporine, which is an inhibitor of a broad spectrum of protein kinases, has shown
cytotoxicity on several human cancer cells. However, the underlying mechanism is not well …